Medicare
January 31, 2014
Prime Healthcare Services Inc. (PHS) is being sued by an employee whistleblower, Karin Berntsen, for allegations under the False Claims Act that they knowingly falsified patients’ admission information, Law360 announced earlier this month.
PHS allegedly directed hospital staff to falsify patients’ diagnoses in order to charge the highest amount to Medicare and...
False Claims Act, Medicaid, Medicaid Fraud, Medicare, Medicare Fraud, Prime Healthcare Services Inc., qui tam lawsuit, Whistleblower Act, whistleblower attorneys
December 19, 2013
Cardiologist Dr. Elie H. Korban (Korban) will pay $1.15 million to resolve False Claims Act allegations that he billed Medicare and Medicaid for medically unnecessary cardiac stent placements, the Justice Department announced today.
Cardiac stents are mesh tubes placed in coronary arteries of patients to keep their arteries open during the treatment of coronary heart disease....
cardiologist, False Claims Act, Kroban, Medicaid, Medicaid Fraud, Medicare, Medicare Fraud, qui tam lawsuit, Whistleblower Act, whistleblower attorneys
December 9, 2013
Lynch Ambulance has agreed to pay more than $3 million to settle a lawsuit, under the False Claims Act, alleging it received overpayments from the Medicare program and other federal health care programs for transporting patients who were not eligible for ambulance transports, the U.S. Attorney’s Office announced last month.
Allegedly, Lynch Ambulance knowingly billed...
False Claims Act, Lynch Ambulance, Medicare, Medicare Fraud, qui tam lawsuit, Whistleblower Act, whistleblower attorneys
November 27, 2013
Vantage Oncology LLC (Vantage) has agreed to pay the government more than $2.08 million to settle allegations, under the False Claims Act, that it knowingly submitted false claims to Medicare for radiation oncology services, the Justice Department announced last week.
The government alleged that Vantage double billed and overbilled Medicare for certain procedures, billed...
False Claims Act, Medicare, Medicare Fraud, qui tam lawsuit, Vantage, Vantage Oncology LLC, Whistleblower Act, whistleblower attorneys
November 20, 2013
The Ensign Group Inc. (Ensign) has agreed to pay $48 million to resolve allegations, under the False Claims Act, that it knowingly submitted or caused the submission of false claims to Medicare for medically unnecessary rehabilitation therapy services, the Justice Department announced today.
Ensign, a skilled nursing provider, allegedly submitted false claims to the...
False Claims Act, Medicare, Medicare Fraud, qui tam lawsuit, The Ensign Group Inc., Whistleblower Act, whistleblower attorneys
November 8, 2013
Hospice of the Comforter Inc. (HOTCI) has agreed to pay $3 million to resolve allegations that it violated the False Claims Act by submitting false claims to the Medicare program for hospice services provided to patients who were not eligible for the Medicare hospice benefit, the Justice Department announced earlier this week.
The government alleged that HOTCI engaged in...
False Claims Act, Hospice of the Comforter Inc., Medicare, Medicare Fraud, qui tam lawsuit, Whistleblower Act, whistleblower attorneys
May 17, 2013
In the largest drug safety settlement of its kind to date, generic drug manufacturer Ranbaxy USA Inc. pleaded guilty to felony charges relating to the manufacture and distribution of adulterated drugs, as well as violation of the False Claims Act, the U.S. Department of Justice announced this week. Ranbaxy agreed to pay a criminal fine and forfeiture amounting to $150...
May 16, 2013
New Jersey-based C.R. Bard has agreed to pay the U.S. government $48.26 million to resolve allegations that it knowingly caused false claims to be submitted to Medicare for brachytherapy seeds used to treat prostate cancer, the U.S. Department of Justice announced this week.
The United States alleged that from 1998 to 2006, Bard violated the Anti-Kickback Statute when the...
December 6, 2012
Healthpoint Ltd. and DFB Pharmaceuticals have agreed to pay up to $48 million to resolve allegations that Healthpoint caused false claims to be submitted to Medicare and Medicaid programs for a non-FDA approved skin ointment, Xenaderm. The U.S. Department of Justice alleges that Healthpoint misrepresented Xenaderm’s regulatory status in its government reports and...
Search Our Site
Subscribe to Our Blogs
Sign up for our newsletter to keep up-to-date with the latest important news from The Chanler Group
Contact Our Team
Use our online contact form, or visit our offices page for more details on how to reach us.
Want to apply for a grant? Check out our Grant Seeker FAQ.
If you want to contact a whistleblower attorney, please take a look at our Whistleblower Questionnaire.